DJIA 16,374.76 23.38 0.14%
NASDAQ 4,733.50 -16.48 -0.35%
S&P 500 1,951.13 2.27 0.12%
market minute promo


company name or ticker

Why Parkinson's Disease-Focused ACADIA Pharmaceuticals is Soaring Today

The company officially submitted a New Drug Application to the FDA for its lead compound Nuplazid, and investors cheered the news.

Acadia Pharmaceuticals (ACAD) Stock Climbs on Drug Application for Parkinson's Treatment

Morning Market Gainers

Benzinga's Top #PreMarket Gainers

Why Piper Jaffray Is Upgrading Acadia Pharmaceuticals After A 25% Decline

Top Analyst Upgrades and Downgrades: Amazon, Monsanto, Schlumberger, SolarCity, Western Digital, Yel

Top Analyst Upgrades and Downgrades: Amazon, Monsanto, Schlumberger, SolarCity, Western Digital, Yelp, Abercrombie and Many More

Trade-Ideas: ACADIA Pharmaceuticals (ACAD) Is Today's Post-Market Leader Stock

Acadia Pharmaceuticals (ACAD) Shares Cross Below 200 DMA

Why ACADIA Pharmaceuticals (ACAD) Could Be Positioned for a Slump

3 Small-Cap Biopharma Stocks I'd Never Short

Bellicum Pharmaceuticals, Exelixis, and Sarepta Therapeutics are three small-cap biopharma stocks that carry too much risk to short. Here's why.
See More Articles...